KRT18P1: A Potential Drug Target Or Biomarker for Diseases (G3879)

Target Name: KRT18P1

NCBI ID: G3879

KRT18P1

Other Name(s): dJ25J6.3 | Keratin 18 pseudogene 1 | keratin 18 pseudogene 1

KRT18P1: A Potential Drug Target Or Biomarker for Diseases

KRT18P1 (dJ25J6.3) is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. Its unique genetic mutation has led to a unique expression of the gene, which has been shown to play a role in the development and progression of these diseases.

The KRT18P1 gene is located on chromosome 25, and its protein product, KRT18P1, is a cell surface glycoprotein that is expressed in many different tissues and cells in the body. The protein is involved in various cellular processes, including cell adhesion, migration, and signaling.

One of the unique features of KRT18P1 is its ability to interact with other proteins that are expressed in the same cell. This interaction has been shown to play a role in the regulation of cellular processes, including cell growth, differentiation, and survival.

In addition to its role in cellular processes, KRT18P1 has also been shown to play a role in the development and progression of various diseases. For example, studies have shown that KRT18P1 is overexpressed in various tissues and cells, including cancer cells, neurodegenerative diseases, and psychiatric disorders.

The overexpression of KRT18P1 has been shown to lead to the formation of aggregates, which can cause a range of cellular and tissue problems, including the development of cancer, neurodegenerative diseases, and psychiatric disorders.

In addition to its role in the development and progression of diseases, KRT18P1 has also been shown to be a potential drug target. Studies have shown that KRT18P1 can be targeted by small molecules, including inhibitors of tyrosine kinase activity, which can inhibit the interaction of KRT18P1 with other proteins.

In addition to its potential as a drug target, KRT18P1 has also been shown to be a potential biomarker for various diseases. For example, studies have shown that KRT18P1 is overexpressed in various tissues and cells, including cancer cells, neurodegenerative diseases, and psychiatric disorders.

In conclusion, KRT18P1 is a gene that has been identified as a potential drug target or biomarker for various diseases. Its unique genetic mutation and ability to interact with other proteins make it an attractive target for small molecule inhibitors. Further research is needed to fully understand the role of KRT18P1 in the development and progression of these diseases, as well as its potential as a drug or biomarker.

Protein Name: Keratin 18 Pseudogene 1

The "KRT18P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRT18P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets